Intellectual Property & Technology; Patent Prosecution & Counseling; Life Sciences & Medical Technology; Intellectual Property Litigation
David Dykeman, who serves as Co-Managing Shareholder of Greenberg Traurig's Boston office and co-chairs the firm's Global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 23 years of experience in patent and intellectual property law. David's practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology.
David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities.
An author of over 50 articles and a speaker at over 45 conferences on intellectual property law, David is the founding co-chair of the American Bar Association's Medical Devices Committee.
J.D., University of Wisconsin Law School; B.S., Mechanical Engineering, Cornell University